Wedge Capital Management L L P NC Boosts Stock Holdings in Envista Holdings Co. (NYSE:NVST)

Wedge Capital Management L L P NC raised its holdings in shares of Envista Holdings Co. (NYSE:NVST) by 0.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 102,309 shares of the company’s stock after buying an additional 569 shares during the period. Wedge Capital Management L L P NC’s holdings in Envista were worth $2,462,000 at the end of the most recent reporting period.

Several other institutional investors have also added to or reduced their stakes in the business. Headinvest LLC purchased a new stake in shares of Envista during the third quarter worth about $28,000. Fifth Third Bancorp boosted its holdings in shares of Envista by 98.1% during the fourth quarter. Fifth Third Bancorp now owns 1,254 shares of the company’s stock worth $30,000 after purchasing an additional 621 shares during the period. Itau Unibanco Holding S.A. purchased a new stake in shares of Envista during the third quarter worth about $47,000. Covestor Ltd boosted its holdings in shares of Envista by 33.9% during the third quarter. Covestor Ltd now owns 2,462 shares of the company’s stock worth $69,000 after purchasing an additional 624 shares during the period. Finally, Signaturefd LLC boosted its holdings in shares of Envista by 1,297.9% during the fourth quarter. Signaturefd LLC now owns 2,614 shares of the company’s stock worth $63,000 after purchasing an additional 2,427 shares during the period.

Envista Stock Up 0.3 %

NVST stock opened at $20.28 on Thursday. Envista Holdings Co. has a 52 week low of $18.95 and a 52 week high of $39.09. The company has a quick ratio of 1.90, a current ratio of 2.23 and a debt-to-equity ratio of 0.33. The firm has a 50-day simple moving average of $21.05 and a 200-day simple moving average of $22.77. The stock has a market capitalization of $3.49 billion, a P/E ratio of -33.25, a P/E/G ratio of 3.77 and a beta of 1.35.

Envista (NYSE:NVST) last announced its quarterly earnings data on Wednesday, February 7th. The company reported $0.29 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.33 by ($0.04). The business had revenue of $645.60 million for the quarter, compared to analysts’ expectations of $638.37 million. Envista had a negative net margin of 3.90% and a positive return on equity of 6.31%. The firm’s revenue was down 2.3% on a year-over-year basis. During the same period in the prior year, the company posted $0.52 EPS. Equities analysts forecast that Envista Holdings Co. will post 1.43 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have commented on NVST shares. William Blair lowered shares of Envista from an “outperform” rating to a “market perform” rating in a report on Thursday, February 8th. TheStreet lowered shares of Envista from a “c” rating to a “d+” rating in a report on Wednesday, February 7th. SVB Leerink started coverage on shares of Envista in a report on Monday, February 26th. They issued an “underperform” rating and a $19.00 price objective for the company. Jefferies Financial Group downgraded shares of Envista from a “buy” rating to a “hold” rating and decreased their target price for the company from $30.00 to $23.00 in a research note on Friday, February 9th. Finally, Leerink Partnrs reissued an “underperform” rating on shares of Envista in a research report on Monday, February 26th. Three analysts have rated the stock with a sell rating, five have issued a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $29.60.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.